No insider purchase over the last 90 days. The latest, by 정연석, was filed 26 Jun 2026.
Aligned Genetics, Inc.: what insiders have been doing
Every trade that managers of Aligned Genetics, Inc. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. 1 insider has disclosed 1 filing since 27 October 2025.
Every open-market trade in the period is a purchase: 1 purchase, from 1 insider, and not a single sale. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 board member.
The most recent open-market purchase was published on 26 June 2026, 137 days ago.
Across the 2,652 companies tracked on its exchange, the median is 7 filings; at 1 filing, this issuer sits below that mark. Over the whole record (from 2021), the tally stands at 7 purchases and 2 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 30,000 sharesShareKRXDART:20260626000562Canonical exit: 24 Sept 2026 (T+90)
- 806,176 sharesShareKRXDART:20231116000358Canonical exit: 6 Feb 2024 (T+90)
- 121,268 sharesShareKRXDART:20231115000326Canonical exit: 6 Feb 2024 (T+90)
- 9,090 sharesShareKRXDART:20231115000330Canonical exit: 6 Feb 2024 (T+90)
- 18,180 sharesKRXDART:20231115000359
- 544,000 sharesShareKRXDART:20231115000323Canonical exit: 6 Feb 2024 (T+90)
- 720,000 sharesShareKRXDART:20231115000316Canonical exit: 6 Feb 2024 (T+90)
- 1,374,800 sharesShareKRXDART:20231115000314Canonical exit: 6 Feb 2024 (T+90)
- 1,646 sharesShareKRXDART:20231024000356
- ●Executives0DART
10 of 10 declarations
About Aligned Genetics, Inc.
Aligné is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
